nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AR—Ergocalciferol—osteoporosis	0.194	0.266	CbGbCtD
Flutamide—AR—Estradiol—osteoporosis	0.101	0.138	CbGbCtD
Flutamide—CYP1B1—Estradiol—osteoporosis	0.0871	0.12	CbGbCtD
Flutamide—CYP1A1—Cholecalciferol—osteoporosis	0.0474	0.0651	CbGbCtD
Flutamide—CYP1A2—Estropipate—osteoporosis	0.0411	0.0564	CbGbCtD
Flutamide—CYP1A1—Estradiol—osteoporosis	0.0382	0.0525	CbGbCtD
Flutamide—CYP2C19—Cholecalciferol—osteoporosis	0.023	0.0315	CbGbCtD
Flutamide—CYP3A5—Estradiol—osteoporosis	0.023	0.0315	CbGbCtD
Flutamide—CYP3A4—Estropipate—osteoporosis	0.0216	0.0296	CbGbCtD
Flutamide—CYP3A4—Calcitriol—osteoporosis	0.0216	0.0296	CbGbCtD
Flutamide—CYP1A2—Conjugated Estrogens—osteoporosis	0.0195	0.0267	CbGbCtD
Flutamide—CYP2C19—Estradiol—osteoporosis	0.0185	0.0254	CbGbCtD
Flutamide—CYP3A4—Ergocalciferol—osteoporosis	0.0172	0.0236	CbGbCtD
Flutamide—CYP1A2—Estradiol—osteoporosis	0.0171	0.0234	CbGbCtD
Flutamide—CYP3A4—Raloxifene—osteoporosis	0.0144	0.0197	CbGbCtD
Flutamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0139	0.0191	CbGbCtD
Flutamide—CYP3A4—Cholecalciferol—osteoporosis	0.0111	0.0152	CbGbCtD
Flutamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0102	0.014	CbGbCtD
Flutamide—CYP3A4—Estradiol—osteoporosis	0.00895	0.0123	CbGbCtD
Flutamide—Ill-defined disorder—Alendronate—osteoporosis	0.000452	0.00206	CcSEcCtD
Flutamide—Vomiting—Calcium Acetate—osteoporosis	0.000452	0.00206	CcSEcCtD
Flutamide—Asthenia—Ergocalciferol—osteoporosis	0.00045	0.00205	CcSEcCtD
Flutamide—Anaemia—Alendronate—osteoporosis	0.00045	0.00205	CcSEcCtD
Flutamide—Oedema peripheral—Risedronate—osteoporosis	0.000442	0.00201	CcSEcCtD
Flutamide—Ill-defined disorder—Ibandronate—osteoporosis	0.00044	0.002	CcSEcCtD
Flutamide—Malaise—Alendronate—osteoporosis	0.000439	0.002	CcSEcCtD
Flutamide—Anaemia—Ibandronate—osteoporosis	0.000438	0.002	CcSEcCtD
Flutamide—Disturbance in sexual arousal—Estradiol—osteoporosis	0.000431	0.00196	CcSEcCtD
Flutamide—Malaise—Ibandronate—osteoporosis	0.000428	0.00195	CcSEcCtD
Flutamide—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000423	0.00193	CcSEcCtD
Flutamide—Nausea—Calcium Acetate—osteoporosis	0.000422	0.00192	CcSEcCtD
Flutamide—Anxiety—Estropipate—osteoporosis	0.00042	0.00191	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000418	0.0019	CcSEcCtD
Flutamide—Haematuria—Zoledronate—osteoporosis	0.000414	0.00189	CcSEcCtD
Flutamide—Discomfort—Alendronate—osteoporosis	0.00041	0.00187	CcSEcCtD
Flutamide—Hypertension—Ibandronate—osteoporosis	0.000409	0.00186	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000405	0.00184	CcSEcCtD
Flutamide—Oedema—Estropipate—osteoporosis	0.000404	0.00184	CcSEcCtD
Flutamide—Anxiety—Ibandronate—osteoporosis	0.000402	0.00183	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000401	0.00183	CcSEcCtD
Flutamide—Hypertension—Calcitriol—osteoporosis	0.000401	0.00183	CcSEcCtD
Flutamide—Constipation—Etidronic acid—osteoporosis	0.000399	0.00182	CcSEcCtD
Flutamide—Discomfort—Ibandronate—osteoporosis	0.000399	0.00182	CcSEcCtD
Flutamide—Anxiety—Calcitriol—osteoporosis	0.000394	0.00179	CcSEcCtD
Flutamide—Skin disorder—Estropipate—osteoporosis	0.000392	0.00179	CcSEcCtD
Flutamide—Discomfort—Calcitriol—osteoporosis	0.000391	0.00178	CcSEcCtD
Flutamide—Feeling abnormal—Etidronic acid—osteoporosis	0.000385	0.00175	CcSEcCtD
Flutamide—Oedema peripheral—Zoledronate—osteoporosis	0.000384	0.00175	CcSEcCtD
Flutamide—Thrombocytopenia—Raloxifene—osteoporosis	0.000383	0.00174	CcSEcCtD
Flutamide—Skin disorder—Raloxifene—osteoporosis	0.00038	0.00173	CcSEcCtD
Flutamide—Skin disorder—Ibandronate—osteoporosis	0.000376	0.00171	CcSEcCtD
Flutamide—Nausea—Ergocalciferol—osteoporosis	0.000373	0.0017	CcSEcCtD
Flutamide—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000372	0.00169	CcSEcCtD
Flutamide—Erythema—Pamidronate—osteoporosis	0.000372	0.00169	CcSEcCtD
Flutamide—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00037	0.00168	CcSEcCtD
Flutamide—Skin disorder—Calcitriol—osteoporosis	0.000368	0.00168	CcSEcCtD
Flutamide—Insomnia—Estropipate—osteoporosis	0.000365	0.00166	CcSEcCtD
Flutamide—Tension—Pamidronate—osteoporosis	0.000365	0.00166	CcSEcCtD
Flutamide—Malaise—Ethinyl Estradiol—osteoporosis	0.000362	0.00165	CcSEcCtD
Flutamide—Anaemia—Risedronate—osteoporosis	0.000361	0.00165	CcSEcCtD
Flutamide—Anorexia—Calcitriol—osteoporosis	0.000361	0.00165	CcSEcCtD
Flutamide—Nervousness—Pamidronate—osteoporosis	0.000361	0.00164	CcSEcCtD
Flutamide—Somnolence—Estropipate—osteoporosis	0.000359	0.00163	CcSEcCtD
Flutamide—Insomnia—Raloxifene—osteoporosis	0.000354	0.00161	CcSEcCtD
Flutamide—Insomnia—Ibandronate—osteoporosis	0.00035	0.00159	CcSEcCtD
Flutamide—Fatigue—Estropipate—osteoporosis	0.000348	0.00158	CcSEcCtD
Flutamide—Constipation—Estropipate—osteoporosis	0.000345	0.00157	CcSEcCtD
Flutamide—Ill-defined disorder—Pamidronate—osteoporosis	0.000345	0.00157	CcSEcCtD
Flutamide—Anaemia—Pamidronate—osteoporosis	0.000343	0.00156	CcSEcCtD
Flutamide—Insomnia—Calcitriol—osteoporosis	0.000343	0.00156	CcSEcCtD
Flutamide—Photosensitivity reaction—Estradiol—osteoporosis	0.000343	0.00156	CcSEcCtD
Flutamide—Anxiety—Ethinyl Estradiol—osteoporosis	0.00034	0.00155	CcSEcCtD
Flutamide—Constipation—Alendronate—osteoporosis	0.00034	0.00155	CcSEcCtD
Flutamide—Erythema—Zoledronate—osteoporosis	0.000339	0.00155	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000339	0.00154	CcSEcCtD
Flutamide—Hyperglycaemia—Estradiol—osteoporosis	0.000339	0.00154	CcSEcCtD
Flutamide—Hypertension—Risedronate—osteoporosis	0.000337	0.00154	CcSEcCtD
Flutamide—Discomfort—Ethinyl Estradiol—osteoporosis	0.000337	0.00154	CcSEcCtD
Flutamide—Somnolence—Calcitriol—osteoporosis	0.000337	0.00153	CcSEcCtD
Flutamide—Decreased appetite—Ibandronate—osteoporosis	0.000336	0.00153	CcSEcCtD
Flutamide—Malaise—Pamidronate—osteoporosis	0.000335	0.00153	CcSEcCtD
Flutamide—Fatigue—Ibandronate—osteoporosis	0.000334	0.00152	CcSEcCtD
Flutamide—Leukopenia—Pamidronate—osteoporosis	0.000333	0.00151	CcSEcCtD
Flutamide—Anxiety—Risedronate—osteoporosis	0.000332	0.00151	CcSEcCtD
Flutamide—Constipation—Ibandronate—osteoporosis	0.000331	0.00151	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00033	0.00151	CcSEcCtD
Flutamide—Pruritus—Etidronic acid—osteoporosis	0.00033	0.0015	CcSEcCtD
Flutamide—Decreased appetite—Calcitriol—osteoporosis	0.000329	0.0015	CcSEcCtD
Flutamide—Feeling abnormal—Alendronate—osteoporosis	0.000328	0.00149	CcSEcCtD
Flutamide—Oedema—Ethinyl Estradiol—osteoporosis	0.000327	0.00149	CcSEcCtD
Flutamide—Erythema—Conjugated Estrogens—osteoporosis	0.000327	0.00149	CcSEcCtD
Flutamide—Jaundice—Estradiol—osteoporosis	0.000326	0.00149	CcSEcCtD
Flutamide—Constipation—Calcitriol—osteoporosis	0.000324	0.00148	CcSEcCtD
Flutamide—Hypertension—Pamidronate—osteoporosis	0.000321	0.00146	CcSEcCtD
Flutamide—Tension—Conjugated Estrogens—osteoporosis	0.000321	0.00146	CcSEcCtD
Flutamide—Diarrhoea—Etidronic acid—osteoporosis	0.000319	0.00145	CcSEcCtD
Flutamide—Haematuria—Estradiol—osteoporosis	0.000319	0.00145	CcSEcCtD
Flutamide—Feeling abnormal—Ibandronate—osteoporosis	0.000319	0.00145	CcSEcCtD
Flutamide—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000318	0.00145	CcSEcCtD
Flutamide—Nervousness—Conjugated Estrogens—osteoporosis	0.000317	0.00145	CcSEcCtD
Flutamide—Anxiety—Pamidronate—osteoporosis	0.000315	0.00144	CcSEcCtD
Flutamide—Ill-defined disorder—Zoledronate—osteoporosis	0.000315	0.00143	CcSEcCtD
Flutamide—Anaemia—Zoledronate—osteoporosis	0.000314	0.00143	CcSEcCtD
Flutamide—Discomfort—Pamidronate—osteoporosis	0.000313	0.00142	CcSEcCtD
Flutamide—Skin disorder—Risedronate—osteoporosis	0.00031	0.00141	CcSEcCtD
Flutamide—Malaise—Zoledronate—osteoporosis	0.000306	0.00139	CcSEcCtD
Flutamide—Confusional state—Pamidronate—osteoporosis	0.000306	0.00139	CcSEcCtD
Flutamide—Leukopenia—Zoledronate—osteoporosis	0.000304	0.00138	CcSEcCtD
Flutamide—Oedema—Pamidronate—osteoporosis	0.000303	0.00138	CcSEcCtD
Flutamide—Hepatitis—Estradiol—osteoporosis	0.0003	0.00137	CcSEcCtD
Flutamide—Thrombocytopenia—Pamidronate—osteoporosis	0.000297	0.00135	CcSEcCtD
Flutamide—Vomiting—Etidronic acid—osteoporosis	0.000297	0.00135	CcSEcCtD
Flutamide—Oedema peripheral—Estradiol—osteoporosis	0.000296	0.00135	CcSEcCtD
Flutamide—Rash—Etidronic acid—osteoporosis	0.000294	0.00134	CcSEcCtD
Flutamide—Dermatitis—Etidronic acid—osteoporosis	0.000294	0.00134	CcSEcCtD
Flutamide—Hypertension—Zoledronate—osteoporosis	0.000293	0.00133	CcSEcCtD
Flutamide—Headache—Etidronic acid—osteoporosis	0.000292	0.00133	CcSEcCtD
Flutamide—Asthenia—Estropipate—osteoporosis	0.00029	0.00132	CcSEcCtD
Flutamide—Anorexia—Pamidronate—osteoporosis	0.000289	0.00132	CcSEcCtD
Flutamide—Insomnia—Risedronate—osteoporosis	0.000289	0.00131	CcSEcCtD
Flutamide—Anxiety—Zoledronate—osteoporosis	0.000288	0.00131	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000287	0.00131	CcSEcCtD
Flutamide—Pruritus—Estropipate—osteoporosis	0.000286	0.0013	CcSEcCtD
Flutamide—Discomfort—Zoledronate—osteoporosis	0.000285	0.0013	CcSEcCtD
Flutamide—Asthenia—Alendronate—osteoporosis	0.000285	0.0013	CcSEcCtD
Flutamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000282	0.00128	CcSEcCtD
Flutamide—Pruritus—Alendronate—osteoporosis	0.000281	0.00128	CcSEcCtD
Flutamide—Constipation—Ethinyl Estradiol—osteoporosis	0.00028	0.00127	CcSEcCtD
Flutamide—Confusional state—Zoledronate—osteoporosis	0.000279	0.00127	CcSEcCtD
Flutamide—Asthenia—Ibandronate—osteoporosis	0.000278	0.00126	CcSEcCtD
Flutamide—Anxiety—Conjugated Estrogens—osteoporosis	0.000277	0.00126	CcSEcCtD
Flutamide—Nausea—Etidronic acid—osteoporosis	0.000277	0.00126	CcSEcCtD
Flutamide—Oedema—Zoledronate—osteoporosis	0.000277	0.00126	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000276	0.00126	CcSEcCtD
Flutamide—Diarrhoea—Estropipate—osteoporosis	0.000276	0.00126	CcSEcCtD
Flutamide—Fatigue—Risedronate—osteoporosis	0.000275	0.00125	CcSEcCtD
Flutamide—Insomnia—Pamidronate—osteoporosis	0.000274	0.00125	CcSEcCtD
Flutamide—Pruritus—Ibandronate—osteoporosis	0.000274	0.00125	CcSEcCtD
Flutamide—Constipation—Risedronate—osteoporosis	0.000273	0.00124	CcSEcCtD
Flutamide—Diarrhoea—Alendronate—osteoporosis	0.000272	0.00124	CcSEcCtD
Flutamide—Asthenia—Calcitriol—osteoporosis	0.000272	0.00124	CcSEcCtD
Flutamide—Thrombocytopenia—Zoledronate—osteoporosis	0.000271	0.00124	CcSEcCtD
Flutamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00027	0.00123	CcSEcCtD
Flutamide—Somnolence—Pamidronate—osteoporosis	0.00027	0.00123	CcSEcCtD
Flutamide—Skin disorder—Zoledronate—osteoporosis	0.000269	0.00123	CcSEcCtD
Flutamide—Pruritus—Calcitriol—osteoporosis	0.000268	0.00122	CcSEcCtD
Flutamide—Diarrhoea—Raloxifene—osteoporosis	0.000268	0.00122	CcSEcCtD
Flutamide—Dizziness—Estropipate—osteoporosis	0.000267	0.00122	CcSEcCtD
Flutamide—Oedema—Conjugated Estrogens—osteoporosis	0.000267	0.00121	CcSEcCtD
Flutamide—Diarrhoea—Ibandronate—osteoporosis	0.000265	0.00121	CcSEcCtD
Flutamide—Anorexia—Zoledronate—osteoporosis	0.000264	0.0012	CcSEcCtD
Flutamide—Decreased appetite—Pamidronate—osteoporosis	0.000264	0.0012	CcSEcCtD
Flutamide—Dizziness—Alendronate—osteoporosis	0.000263	0.0012	CcSEcCtD
Flutamide—Erythema—Estradiol—osteoporosis	0.000262	0.00119	CcSEcCtD
Flutamide—Fatigue—Pamidronate—osteoporosis	0.000261	0.00119	CcSEcCtD
Flutamide—Constipation—Pamidronate—osteoporosis	0.000259	0.00118	CcSEcCtD
Flutamide—Diarrhoea—Calcitriol—osteoporosis	0.000259	0.00118	CcSEcCtD
Flutamide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000259	0.00118	CcSEcCtD
Flutamide—Dizziness—Raloxifene—osteoporosis	0.000259	0.00118	CcSEcCtD
Flutamide—Tension—Estradiol—osteoporosis	0.000257	0.00117	CcSEcCtD
Flutamide—Vomiting—Estropipate—osteoporosis	0.000257	0.00117	CcSEcCtD
Flutamide—Dizziness—Ibandronate—osteoporosis	0.000256	0.00117	CcSEcCtD
Flutamide—Rash—Estropipate—osteoporosis	0.000255	0.00116	CcSEcCtD
Flutamide—Dermatitis—Estropipate—osteoporosis	0.000254	0.00116	CcSEcCtD
Flutamide—Anorexia—Conjugated Estrogens—osteoporosis	0.000254	0.00116	CcSEcCtD
Flutamide—Nervousness—Estradiol—osteoporosis	0.000254	0.00116	CcSEcCtD
Flutamide—Headache—Estropipate—osteoporosis	0.000253	0.00115	CcSEcCtD
Flutamide—Vomiting—Alendronate—osteoporosis	0.000253	0.00115	CcSEcCtD
Flutamide—Rash—Alendronate—osteoporosis	0.000251	0.00114	CcSEcCtD
Flutamide—Insomnia—Zoledronate—osteoporosis	0.000251	0.00114	CcSEcCtD
Flutamide—Dermatitis—Alendronate—osteoporosis	0.00025	0.00114	CcSEcCtD
Flutamide—Feeling abnormal—Pamidronate—osteoporosis	0.00025	0.00114	CcSEcCtD
Flutamide—Headache—Alendronate—osteoporosis	0.000249	0.00113	CcSEcCtD
Flutamide—Vomiting—Raloxifene—osteoporosis	0.000249	0.00113	CcSEcCtD
Flutamide—Rash—Raloxifene—osteoporosis	0.000247	0.00112	CcSEcCtD
Flutamide—Dermatitis—Raloxifene—osteoporosis	0.000246	0.00112	CcSEcCtD
Flutamide—Somnolence—Zoledronate—osteoporosis	0.000246	0.00112	CcSEcCtD
Flutamide—Vomiting—Ibandronate—osteoporosis	0.000246	0.00112	CcSEcCtD
Flutamide—Headache—Raloxifene—osteoporosis	0.000245	0.00112	CcSEcCtD
Flutamide—Rash—Ibandronate—osteoporosis	0.000244	0.00111	CcSEcCtD
Flutamide—Dermatitis—Ibandronate—osteoporosis	0.000244	0.00111	CcSEcCtD
Flutamide—Ill-defined disorder—Estradiol—osteoporosis	0.000243	0.00111	CcSEcCtD
Flutamide—Headache—Ibandronate—osteoporosis	0.000243	0.0011	CcSEcCtD
Flutamide—Insomnia—Conjugated Estrogens—osteoporosis	0.000241	0.0011	CcSEcCtD
Flutamide—Vomiting—Calcitriol—osteoporosis	0.000241	0.0011	CcSEcCtD
Flutamide—Decreased appetite—Zoledronate—osteoporosis	0.000241	0.0011	CcSEcCtD
Flutamide—Nausea—Estropipate—osteoporosis	0.00024	0.00109	CcSEcCtD
Flutamide—Rash—Calcitriol—osteoporosis	0.000239	0.00109	CcSEcCtD
Flutamide—Fatigue—Zoledronate—osteoporosis	0.000239	0.00109	CcSEcCtD
Flutamide—Dermatitis—Calcitriol—osteoporosis	0.000239	0.00109	CcSEcCtD
Flutamide—Headache—Calcitriol—osteoporosis	0.000237	0.00108	CcSEcCtD
Flutamide—Somnolence—Conjugated Estrogens—osteoporosis	0.000237	0.00108	CcSEcCtD
Flutamide—Constipation—Zoledronate—osteoporosis	0.000237	0.00108	CcSEcCtD
Flutamide—Nausea—Alendronate—osteoporosis	0.000236	0.00108	CcSEcCtD
Flutamide—Malaise—Estradiol—osteoporosis	0.000236	0.00107	CcSEcCtD
Flutamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000235	0.00107	CcSEcCtD
Flutamide—Nausea—Raloxifene—osteoporosis	0.000232	0.00106	CcSEcCtD
Flutamide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000232	0.00106	CcSEcCtD
Flutamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000231	0.00105	CcSEcCtD
Flutamide—Fatigue—Conjugated Estrogens—osteoporosis	0.00023	0.00105	CcSEcCtD
Flutamide—Nausea—Ibandronate—osteoporosis	0.00023	0.00105	CcSEcCtD
Flutamide—Asthenia—Risedronate—osteoporosis	0.000229	0.00104	CcSEcCtD
Flutamide—Feeling abnormal—Zoledronate—osteoporosis	0.000228	0.00104	CcSEcCtD
Flutamide—Constipation—Conjugated Estrogens—osteoporosis	0.000228	0.00104	CcSEcCtD
Flutamide—Hypertension—Estradiol—osteoporosis	0.000226	0.00103	CcSEcCtD
Flutamide—Pruritus—Risedronate—osteoporosis	0.000226	0.00103	CcSEcCtD
Flutamide—Nausea—Calcitriol—osteoporosis	0.000225	0.00103	CcSEcCtD
Flutamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000224	0.00102	CcSEcCtD
Flutamide—Anxiety—Estradiol—osteoporosis	0.000222	0.00101	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000221	0.00101	CcSEcCtD
Flutamide—Discomfort—Estradiol—osteoporosis	0.00022	0.001	CcSEcCtD
Flutamide—Diarrhoea—Risedronate—osteoporosis	0.000218	0.000994	CcSEcCtD
Flutamide—Asthenia—Pamidronate—osteoporosis	0.000218	0.000991	CcSEcCtD
Flutamide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000216	0.000985	CcSEcCtD
Flutamide—Confusional state—Estradiol—osteoporosis	0.000215	0.00098	CcSEcCtD
Flutamide—Pruritus—Pamidronate—osteoporosis	0.000215	0.000977	CcSEcCtD
Flutamide—Oedema—Estradiol—osteoporosis	0.000213	0.000972	CcSEcCtD
Flutamide—Dizziness—Risedronate—osteoporosis	0.000211	0.000961	CcSEcCtD
Flutamide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000208	0.000947	CcSEcCtD
Flutamide—Diarrhoea—Pamidronate—osteoporosis	0.000207	0.000945	CcSEcCtD
Flutamide—Skin disorder—Estradiol—osteoporosis	0.000207	0.000944	CcSEcCtD
Flutamide—Rash—Ethinyl Estradiol—osteoporosis	0.000206	0.00094	CcSEcCtD
Flutamide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000206	0.000939	CcSEcCtD
Flutamide—Headache—Ethinyl Estradiol—osteoporosis	0.000205	0.000934	CcSEcCtD
Flutamide—Vomiting—Risedronate—osteoporosis	0.000203	0.000924	CcSEcCtD
Flutamide—Rash—Risedronate—osteoporosis	0.000201	0.000916	CcSEcCtD
Flutamide—Dermatitis—Risedronate—osteoporosis	0.000201	0.000915	CcSEcCtD
Flutamide—Dizziness—Pamidronate—osteoporosis	0.000201	0.000913	CcSEcCtD
Flutamide—Headache—Risedronate—osteoporosis	0.0002	0.00091	CcSEcCtD
Flutamide—Asthenia—Zoledronate—osteoporosis	0.000199	0.000905	CcSEcCtD
Flutamide—Pruritus—Zoledronate—osteoporosis	0.000196	0.000893	CcSEcCtD
Flutamide—Nausea—Ethinyl Estradiol—osteoporosis	0.000194	0.000885	CcSEcCtD
Flutamide—Insomnia—Estradiol—osteoporosis	0.000193	0.000879	CcSEcCtD
Flutamide—Vomiting—Pamidronate—osteoporosis	0.000193	0.000878	CcSEcCtD
Flutamide—Asthenia—Conjugated Estrogens—osteoporosis	0.000191	0.000872	CcSEcCtD
Flutamide—Rash—Pamidronate—osteoporosis	0.000191	0.000871	CcSEcCtD
Flutamide—Dermatitis—Pamidronate—osteoporosis	0.000191	0.00087	CcSEcCtD
Flutamide—Headache—Pamidronate—osteoporosis	0.00019	0.000865	CcSEcCtD
Flutamide—Somnolence—Estradiol—osteoporosis	0.00019	0.000864	CcSEcCtD
Flutamide—Diarrhoea—Zoledronate—osteoporosis	0.00019	0.000863	CcSEcCtD
Flutamide—Nausea—Risedronate—osteoporosis	0.000189	0.000863	CcSEcCtD
Flutamide—Pruritus—Conjugated Estrogens—osteoporosis	0.000189	0.000859	CcSEcCtD
Flutamide—Decreased appetite—Estradiol—osteoporosis	0.000186	0.000845	CcSEcCtD
Flutamide—Fatigue—Estradiol—osteoporosis	0.000184	0.000838	CcSEcCtD
Flutamide—Dizziness—Zoledronate—osteoporosis	0.000183	0.000834	CcSEcCtD
Flutamide—Constipation—Estradiol—osteoporosis	0.000183	0.000831	CcSEcCtD
Flutamide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000182	0.000831	CcSEcCtD
Flutamide—Nausea—Pamidronate—osteoporosis	0.00018	0.00082	CcSEcCtD
Flutamide—Dizziness—Conjugated Estrogens—osteoporosis	0.000176	0.000803	CcSEcCtD
Flutamide—Vomiting—Zoledronate—osteoporosis	0.000176	0.000802	CcSEcCtD
Flutamide—Feeling abnormal—Estradiol—osteoporosis	0.000176	0.000801	CcSEcCtD
Flutamide—Rash—Zoledronate—osteoporosis	0.000175	0.000795	CcSEcCtD
Flutamide—Dermatitis—Zoledronate—osteoporosis	0.000174	0.000795	CcSEcCtD
Flutamide—Headache—Zoledronate—osteoporosis	0.000174	0.00079	CcSEcCtD
Flutamide—Vomiting—Conjugated Estrogens—osteoporosis	0.00017	0.000772	CcSEcCtD
Flutamide—Rash—Conjugated Estrogens—osteoporosis	0.000168	0.000766	CcSEcCtD
Flutamide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000168	0.000765	CcSEcCtD
Flutamide—Headache—Conjugated Estrogens—osteoporosis	0.000167	0.000761	CcSEcCtD
Flutamide—Nausea—Zoledronate—osteoporosis	0.000165	0.000749	CcSEcCtD
Flutamide—Nausea—Conjugated Estrogens—osteoporosis	0.000158	0.000722	CcSEcCtD
Flutamide—Asthenia—Estradiol—osteoporosis	0.000153	0.000698	CcSEcCtD
Flutamide—Pruritus—Estradiol—osteoporosis	0.000151	0.000688	CcSEcCtD
Flutamide—Diarrhoea—Estradiol—osteoporosis	0.000146	0.000665	CcSEcCtD
Flutamide—Dizziness—Estradiol—osteoporosis	0.000141	0.000643	CcSEcCtD
Flutamide—Vomiting—Estradiol—osteoporosis	0.000136	0.000618	CcSEcCtD
Flutamide—Rash—Estradiol—osteoporosis	0.000135	0.000613	CcSEcCtD
Flutamide—Dermatitis—Estradiol—osteoporosis	0.000134	0.000612	CcSEcCtD
Flutamide—Headache—Estradiol—osteoporosis	0.000134	0.000609	CcSEcCtD
Flutamide—Nausea—Estradiol—osteoporosis	0.000127	0.000577	CcSEcCtD
Flutamide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000118	0.00228	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—ESR1—osteoporosis	0.000117	0.00227	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000114	0.00221	CbGpPWpGaD
Flutamide—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000112	0.00218	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000112	0.00218	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—IRS1—osteoporosis	0.000109	0.00212	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—IL6—osteoporosis	0.000107	0.00209	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000103	0.002	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000102	0.00199	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	0.000101	0.00196	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	0.0001	0.00194	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.0001	0.00194	CbGpPWpGaD
Flutamide—AR—Gene Expression—U2AF1—osteoporosis	9.97e-05	0.00194	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	9.84e-05	0.00191	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	9.77e-05	0.0019	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.71e-05	0.00189	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	9.69e-05	0.00188	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.66e-05	0.00188	CbGpPWpGaD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.64e-05	0.00187	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	9.63e-05	0.00187	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.55e-05	0.00186	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.2e-05	0.00179	CbGpPWpGaD
Flutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.19e-05	0.00179	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.11e-05	0.00177	CbGpPWpGaD
Flutamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.08e-05	0.00176	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	8.52e-05	0.00165	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	8.4e-05	0.00163	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	8.38e-05	0.00163	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	8.38e-05	0.00163	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.12e-05	0.00158	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	8.05e-05	0.00156	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	8.03e-05	0.00156	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	8.01e-05	0.00156	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.95e-05	0.00154	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	7.94e-05	0.00154	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—ESR2—osteoporosis	7.93e-05	0.00154	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—POMC—osteoporosis	7.85e-05	0.00153	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.61e-05	0.00148	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.55e-05	0.00147	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	7.54e-05	0.00146	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	7.48e-05	0.00145	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	7.48e-05	0.00145	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.46e-05	0.00145	CbGpPWpGaD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.45e-05	0.00145	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.44e-05	0.00144	CbGpPWpGaD
Flutamide—AR—Gene Expression—RPL24—osteoporosis	7.41e-05	0.00144	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PKM—osteoporosis	7.41e-05	0.00144	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—FDPS—osteoporosis	7.41e-05	0.00144	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.36e-05	0.00143	CbGpPWpGaD
Flutamide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.16e-05	0.00139	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GPD2—osteoporosis	7.02e-05	0.00136	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PGLS—osteoporosis	7.02e-05	0.00136	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	6.59e-05	0.00128	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	6.57e-05	0.00128	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.53e-05	0.00127	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	6.5e-05	0.00126	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ATIC—osteoporosis	6.42e-05	0.00125	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PNP—osteoporosis	6.42e-05	0.00125	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—VDR—osteoporosis	6.3e-05	0.00122	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.19e-05	0.0012	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.18e-05	0.0012	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	6.08e-05	0.00118	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.02e-05	0.00117	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.88e-05	0.00114	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.81e-05	0.00113	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.53e-05	0.00107	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	5.52e-05	0.00107	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CA2—osteoporosis	5.46e-05	0.00106	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—OXCT1—osteoporosis	5.46e-05	0.00106	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MGLL—osteoporosis	5.32e-05	0.00103	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	5.13e-05	0.000997	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	5.12e-05	0.000995	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—POMC—osteoporosis	5.12e-05	0.000995	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	5.11e-05	0.000992	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	5.06e-05	0.000983	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.04e-05	0.000979	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.03e-05	0.000976	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.02e-05	0.000975	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5e-05	0.000972	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—POMC—osteoporosis	4.84e-05	0.00094	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PKM—osteoporosis	4.83e-05	0.000938	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—FDPS—osteoporosis	4.83e-05	0.000938	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.81e-05	0.000935	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.81e-05	0.000935	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—ESR1—osteoporosis	4.81e-05	0.000935	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	4.77e-05	0.000927	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	4.77e-05	0.000927	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.69e-05	0.000912	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.69e-05	0.000912	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PGLS—osteoporosis	4.58e-05	0.000889	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GPD2—osteoporosis	4.58e-05	0.000889	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—FDPS—osteoporosis	4.56e-05	0.000886	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PKM—osteoporosis	4.56e-05	0.000886	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—IDH2—osteoporosis	4.52e-05	0.000879	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.48e-05	0.00087	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	4.45e-05	0.000865	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PGLS—osteoporosis	4.32e-05	0.00084	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GPD2—osteoporosis	4.32e-05	0.00084	CbGpPWpGaD
Flutamide—AR—Gene Expression—PSMA5—osteoporosis	4.28e-05	0.000831	CbGpPWpGaD
Flutamide—AR—Gene Expression—PSMA2—osteoporosis	4.28e-05	0.000831	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP27A1—osteoporosis	4.25e-05	0.000826	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ATIC—osteoporosis	4.19e-05	0.000813	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PNP—osteoporosis	4.19e-05	0.000813	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ACP5—osteoporosis	4.14e-05	0.000804	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.09e-05	0.000795	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.09e-05	0.000794	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.96e-05	0.000769	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—POMC—osteoporosis	3.96e-05	0.000769	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ATIC—osteoporosis	3.96e-05	0.000768	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PNP—osteoporosis	3.96e-05	0.000768	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.91e-05	0.000759	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TPI1—osteoporosis	3.85e-05	0.000747	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR2—osteoporosis	3.82e-05	0.000742	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.75e-05	0.000729	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PKM—osteoporosis	3.73e-05	0.000725	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—FDPS—osteoporosis	3.73e-05	0.000725	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—P4HB—osteoporosis	3.62e-05	0.000703	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—OXCT1—osteoporosis	3.56e-05	0.000692	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA2—osteoporosis	3.56e-05	0.000692	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GAPDH—osteoporosis	3.55e-05	0.00069	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PGLS—osteoporosis	3.54e-05	0.000687	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GPD2—osteoporosis	3.54e-05	0.000687	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MGLL—osteoporosis	3.47e-05	0.000674	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—RAP1A—osteoporosis	3.46e-05	0.000672	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA2—osteoporosis	3.36e-05	0.000653	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—OXCT1—osteoporosis	3.36e-05	0.000653	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MGLL—osteoporosis	3.28e-05	0.000637	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PNP—osteoporosis	3.24e-05	0.000629	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ATIC—osteoporosis	3.24e-05	0.000629	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.19e-05	0.00062	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.09e-05	0.0006	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—POMC—osteoporosis	3.08e-05	0.000599	CbGpPWpGaD
Flutamide—AR—Gene Expression—VDR—osteoporosis	3.03e-05	0.000589	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.02e-05	0.000586	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—IDH2—osteoporosis	2.95e-05	0.000573	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PKM—osteoporosis	2.91e-05	0.000565	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—FDPS—osteoporosis	2.91e-05	0.000565	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ENO1—osteoporosis	2.8e-05	0.000543	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—IDH2—osteoporosis	2.79e-05	0.000541	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.77e-05	0.000539	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PGLS—osteoporosis	2.76e-05	0.000536	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GPD2—osteoporosis	2.76e-05	0.000536	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSMA2—osteoporosis	2.75e-05	0.000535	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSMA5—osteoporosis	2.75e-05	0.000535	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA2—osteoporosis	2.75e-05	0.000535	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—OXCT1—osteoporosis	2.75e-05	0.000535	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ACP5—osteoporosis	2.7e-05	0.000524	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MGLL—osteoporosis	2.68e-05	0.000521	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP27A1—osteoporosis	2.62e-05	0.000509	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ACP5—osteoporosis	2.55e-05	0.000495	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.53e-05	0.000491	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PNP—osteoporosis	2.52e-05	0.00049	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ATIC—osteoporosis	2.52e-05	0.00049	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.52e-05	0.000489	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TPI1—osteoporosis	2.51e-05	0.000487	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—osteoporosis	2.5e-05	0.000486	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—POMC—osteoporosis	2.38e-05	0.000462	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TPI1—osteoporosis	2.37e-05	0.00046	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—P4HB—osteoporosis	2.36e-05	0.000458	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR1—osteoporosis	2.32e-05	0.00045	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GAPDH—osteoporosis	2.31e-05	0.00045	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—IDH2—osteoporosis	2.28e-05	0.000443	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—RAP1A—osteoporosis	2.25e-05	0.000438	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—FDPS—osteoporosis	2.24e-05	0.000436	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PKM—osteoporosis	2.24e-05	0.000436	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP19A1—osteoporosis	2.23e-05	0.000434	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—P4HB—osteoporosis	2.23e-05	0.000433	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GAPDH—osteoporosis	2.19e-05	0.000425	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA2—osteoporosis	2.14e-05	0.000417	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—OXCT1—osteoporosis	2.14e-05	0.000417	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.14e-05	0.000417	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—RAP1A—osteoporosis	2.13e-05	0.000414	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PGLS—osteoporosis	2.13e-05	0.000413	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPD2—osteoporosis	2.13e-05	0.000413	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MGLL—osteoporosis	2.09e-05	0.000406	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ACP5—osteoporosis	2.09e-05	0.000405	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.06e-05	0.0004	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.97e-05	0.000383	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ATIC—osteoporosis	1.95e-05	0.000378	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PNP—osteoporosis	1.95e-05	0.000378	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TPI1—osteoporosis	1.94e-05	0.000377	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.86e-05	0.000361	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ADCY5—osteoporosis	1.83e-05	0.000355	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—P4HB—osteoporosis	1.82e-05	0.000354	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO1—osteoporosis	1.82e-05	0.000354	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GPX1—osteoporosis	1.82e-05	0.000354	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSMA2—osteoporosis	1.8e-05	0.000349	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSMA5—osteoporosis	1.8e-05	0.000349	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GAPDH—osteoporosis	1.79e-05	0.000348	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—IDH2—osteoporosis	1.78e-05	0.000345	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—RAP1A—osteoporosis	1.74e-05	0.000339	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ENO1—osteoporosis	1.72e-05	0.000334	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSMA2—osteoporosis	1.7e-05	0.00033	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSMA5—osteoporosis	1.7e-05	0.00033	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MTHFR—osteoporosis	1.68e-05	0.000326	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.67e-05	0.000325	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA2—osteoporosis	1.65e-05	0.000321	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—OXCT1—osteoporosis	1.65e-05	0.000321	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ACP5—osteoporosis	1.63e-05	0.000316	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MGLL—osteoporosis	1.61e-05	0.000313	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.6e-05	0.000312	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.52e-05	0.000295	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TPI1—osteoporosis	1.51e-05	0.000293	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.46e-05	0.000283	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—P4HB—osteoporosis	1.42e-05	0.000276	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO1—osteoporosis	1.41e-05	0.000274	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GAPDH—osteoporosis	1.39e-05	0.000271	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSMA2—osteoporosis	1.39e-05	0.00027	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSMA5—osteoporosis	1.39e-05	0.00027	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.38e-05	0.000267	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—IDH2—osteoporosis	1.37e-05	0.000266	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RAP1A—osteoporosis	1.36e-05	0.000264	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—POMC—osteoporosis	1.34e-05	0.000261	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.29e-05	0.00025	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ACP5—osteoporosis	1.25e-05	0.000244	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—osteoporosis	1.21e-05	0.000234	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ADCY5—osteoporosis	1.19e-05	0.000231	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GPX1—osteoporosis	1.19e-05	0.00023	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.18e-05	0.00023	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TPI1—osteoporosis	1.17e-05	0.000227	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.13e-05	0.000219	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADCY5—osteoporosis	1.12e-05	0.000218	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GPX1—osteoporosis	1.12e-05	0.000218	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO1—osteoporosis	1.1e-05	0.000213	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—P4HB—osteoporosis	1.1e-05	0.000213	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—osteoporosis	1.09e-05	0.000213	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSMA5—osteoporosis	1.08e-05	0.00021	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSMA2—osteoporosis	1.08e-05	0.00021	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GAPDH—osteoporosis	1.08e-05	0.000209	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RAP1A—osteoporosis	1.05e-05	0.000204	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—osteoporosis	1.03e-05	0.000201	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADCY5—osteoporosis	9.2e-06	0.000179	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GPX1—osteoporosis	9.17e-06	0.000178	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.78e-06	0.00017	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—POMC—osteoporosis	8.76e-06	0.00017	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO1—osteoporosis	8.47e-06	0.000165	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—osteoporosis	8.46e-06	0.000164	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSMA2—osteoporosis	8.35e-06	0.000162	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSMA5—osteoporosis	8.35e-06	0.000162	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—POMC—osteoporosis	8.27e-06	0.000161	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADCY5—osteoporosis	7.17e-06	0.000139	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GPX1—osteoporosis	7.15e-06	0.000139	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.77e-06	0.000132	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—POMC—osteoporosis	6.77e-06	0.000131	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—osteoporosis	6.59e-06	0.000128	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADCY5—osteoporosis	5.53e-06	0.000108	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPX1—osteoporosis	5.51e-06	0.000107	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—POMC—osteoporosis	5.27e-06	0.000102	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—osteoporosis	5.09e-06	9.89e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—POMC—osteoporosis	4.07e-06	7.91e-05	CbGpPWpGaD
